In CCl4-induced liver fibrosis model, TEVs treatment can significantly improve the pathological changes of liver tissue through inhibit collagen deposition, reduce the number of lipid droplets in liver tissue, and reduce serum AST and ALT levels. This evidence concerns the gene GPT and Hepatic fibrosis.